QQ客服 官方微博 反馈留言

浏览/检索结果: 共22条，第1-10条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 RECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis 期刊论文 BMC CANCER, 2018, 卷号: 18 作者:  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei;  Ridolfi, Antonia;  Dezzani, Luca 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Asians  Everolimus  Ethnicity  Clear-cell metastatic renal cell carcinoma  Sequence   RECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis 期刊论文 2018, 卷号: 18, 期号: 1, 页码: 195 作者:  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei;  Ridolfi, Antonia;  Dezzani, Luca 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 Asians  Everolimus  Ethnicity  Clear-cell metastatic renal cell carcinoma  Sequence   RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients with metastatic renal cell carcinoma (mRCC): anti-vegf cohort subanalysis 会议论文 作者:  Cosgriff, Thomas;  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei;  Karpenko, Andrey 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 RECORD-4 phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Final OS analysis. 会议论文 作者:  Cosgriff, Thomas;  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei;  Karpenko, Andrey 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients with metastatic renal cell carcinoma (mRCC): anti-VEGF cohort subanalysis 会议论文 作者:  Morgan, Liza;  Cosgriff, Thomas;  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 RECORD-4 multicenter phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Anti-VEGF cohort subanalysis. 会议论文 作者:  Cosgriff, Thomas;  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei;  Karpenko, Andrey 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 RECORD-4 multicenter phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Anti-VEGF cohort subanalysis. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2016-01-10 作者:  Cosgriff, Thomas;  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei;  Karpenko, Andrey 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients with metastatic renal cell carcinoma (mRCC): anti-VEGF cohort subanalysis 会议论文 BJU INTERNATIONAL, 2016-12-01 作者:  Cosgriff, Thomas;  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei;  Karpenko, Andrey 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/04 RECORD-4 phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Final OS analysis. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2016-01-10 作者:  Cosgriff, Thomas;  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei;  Karpenko, Andrey 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04 RECORD-4 phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Final OS analysis. 期刊论文 2016, 卷号: 34, 期号: 2 作者:  Cosgriff, Thomas;  Yang, Lin;  Alyasova, Anna;  Ye, Dingwei;  Karpenko, Andrey 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04